103 related articles for article (PubMed ID: 22027651)
1. Genetic polymorphisms of xenobiotic-metabolizing enzymes influence the risk of pulmonary emphysema.
Kukkonen MK; Hämäläinen S; Kaleva S; Vehmas T; Huuskonen MS; Oksa P; Vainio H; Piirilä P; Hirvonen A
Pharmacogenet Genomics; 2011 Dec; 21(12):876-83. PubMed ID: 22027651
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility for emphysematous changes of the lung in Japanese.
Budhi A; Hiyama K; Isobe T; Oshima Y; Hara H; Maeda H; Kohno N
Int J Mol Med; 2003 Mar; 11(3):321-9. PubMed ID: 12579334
[TBL] [Abstract][Full Text] [Related]
3. Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes.
Skjelbred CF; Svendsen M; Haugan V; Eek AK; Clausen KO; Kure EH; Tuimala JT; Svendsen MV; Norppa H; Hansteen IL
Carcinogenesis; 2011 Mar; 32(3):399-405. PubMed ID: 21097530
[TBL] [Abstract][Full Text] [Related]
4. A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.
Spurdle AB; Chang JH; Byrnes GB; Chen X; Dite GS; McCredie MR; Giles GG; Southey MC; Chenevix-Trench G; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):769-74. PubMed ID: 17416769
[TBL] [Abstract][Full Text] [Related]
5. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
6. Genetic susceptibility to asbestos-related fibrotic pleuropulmonary changes.
Kukkonen MK; Hämäläinen S; Kaleva S; Vehmas T; Huuskonen MS; Oksa P; Vainio H; Piirilä P; Hirvonen A
Eur Respir J; 2011 Sep; 38(3):672-8. PubMed ID: 20847076
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma.
Casson AG; Zheng Z; Porter GA; Guernsey DL
Cancer Detect Prev; 2006; 30(5):423-31. PubMed ID: 17064856
[TBL] [Abstract][Full Text] [Related]
8. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
Brockmöller J; Cascorbi I; Kerb R; Roots I
Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
11. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors.
Malik MA; Upadhyay R; Mittal RD; Zargar SA; Mittal B
Nutr Cancer; 2010; 62(6):734-42. PubMed ID: 20661821
[TBL] [Abstract][Full Text] [Related]
12. [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers].
Rusinova GG; Azizova TV; Viazovskaia NS; Glazkova IV; Gur'ianov MIu; Osovets SV
Radiats Biol Radioecol; 2014; 54(4):350-9. PubMed ID: 25775823
[TBL] [Abstract][Full Text] [Related]
13. Correlation of EPHX1, GSTP1, GSTM1, and GSTT1 genetic polymorphisms with antioxidative stress markers in chronic obstructive pulmonary disease.
Lakhdar R; Denden S; Mouhamed MH; Chalgoum A; Leban N; Knani J; Lefranc G; Miled A; Ben Chibani J; Khelil AH
Exp Lung Res; 2011 May; 37(4):195-204. PubMed ID: 21309732
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
15. Do smoking and polymorphisms in xenobiotic metabolizing enzymes affect the histological stage and grade of bladder tumors?
Ouerhani S; Rouissi K; Marrakchi R; Riadh Ben Slama M; Sfaxi M; Ayed M; Chebil M; Elgaaied A
Bull Cancer; 2009 May; 96(5):E23-9. PubMed ID: 19467981
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.
Safarinejad MR; Shafiei N; Safarinejad SH
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):105-13. PubMed ID: 21243008
[TBL] [Abstract][Full Text] [Related]
17. High order interactions of xenobiotic metabolizing genes and P53 codon 72 polymorphisms in acute leukemia.
Chauhan PS; Ihsan R; Mishra AK; Yadav DS; Saluja S; Mittal V; Saxena S; Kapur S
Environ Mol Mutagen; 2012 Oct; 53(8):619-30. PubMed ID: 22930568
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the polymorphic alleles of genes encoding phase 1 and phase 2 detoxication enzymes in patients with endometriosis].
Ivashchenko TE; Shved NIu; Kramareva NA; Aĭlamazian EK; Baranov VS
Genetika; 2003 Apr; 39(4):525-9. PubMed ID: 12760253
[TBL] [Abstract][Full Text] [Related]
19. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
